1,429
Views
0
CrossRef citations to date
0
Altmetric
Foreword

Novel Biomarkers of Acute Kidney Injury: Time for Implementation?

Pages 1185-1188 | Published online: 19 Dec 2014
 

Financial & competing interests disclosure

ZH Endre has received honoraria as a member of the Novartis Australia Medical Advisory Board. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

ZH Endre has received honoraria as a member of the Novartis Australia Medical Advisory Board. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.